Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of ISHITA DRUGS. For more details, see the ISHITA DRUGS quarterly results and ISHITA DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.0 |
No. of shares | m | 2.99 |
1 Week | % | -0.6 |
1 Month | % | 12.2 |
1 Year | % | 29.8 |
52 week H/L | Rs | 98.4/46.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ISHITA DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 23 | 22 | 35 | 54 | 80 | |
Low | Rs | 11 | 10 | 10 | 27 | 40 | |
Sales per share (Unadj.) | Rs | 30.4 | 49.6 | 46.7 | 47.1 | 40.4 | |
Earnings per share (Unadj.) | Rs | 1.2 | 1.8 | 2.8 | 2.7 | 1.9 | |
Diluted earnings per share | Rs | 1.2 | 1.8 | 2.8 | 2.7 | 1.9 | |
Cash flow per share (Unadj.) | Rs | 1.7 | 2.4 | 3.3 | 3.1 | 2.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 21.5 | 23.3 | 26.1 | 28.7 | 30.7 | |
Adj. book value per share | Rs | 21.4 | 23.3 | 26.1 | 28.7 | 30.7 | |
Shares outstanding (eoy) | m | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | |
Price / Sales ratio | x | 0.6 | 0.3 | 0.5 | 0.9 | 1.5 | |
Avg P/E ratio | x | 14.4 | 8.8 | 8.2 | 15.2 | 30.8 | |
P/CF ratio (eoy) | x | 10.0 | 6.7 | 7.0 | 13.1 | 25.2 | |
Price / Book Value ratio | x | 0.8 | 0.7 | 0.9 | 1.4 | 1.9 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 51 | 48 | 68 | 122 | 178 | |
Total wages/salary | Rs m | 7 | 8 | 8 | 8 | 8 |
ISHITA DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 91 | 148 | 139 | 141 | 121 | |
Other income | Rs m | 2 | 2 | 3 | 1 | 2 | |
Total revenues | Rs m | 93 | 150 | 143 | 142 | 123 | |
Gross profit | Rs m | 5 | 8 | 9 | 11 | 8 | |
Depreciation | Rs m | 2 | 2 | 1 | 1 | 1 | |
Interest | Rs m | 1 | 0 | 0 | 0 | 1 | |
Profit before tax | Rs m | 5 | 7 | 11 | 10 | 8 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1 | 2 | 2 | 2 | 2 | |
Profit after tax | Rs m | 4 | 5 | 8 | 8 | 6 | |
Gross profit margin | % | 5.7 | 5.1 | 6.6 | 7.7 | 6.3 | |
Effective tax rate | % | 24.0 | 23.3 | 21.3 | 22.8 | 25.9 | |
Net profit margin | % | 3.9 | 3.7 | 5.9 | 5.7 | 4.8 |
ISHITA DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 68 | 82 | 80 | 100 | 102 | |
Current liabilities | Rs m | 17 | 25 | 14 | 26 | 20 | |
Net working cap to sales | % | 55.9 | 38.1 | 47.0 | 52.6 | 67.6 | |
Current ratio | x | 3.9 | 3.3 | 5.6 | 3.8 | 5.0 | |
Inventory Days | Days | 164 | 132 | 83 | 107 | 105 | |
Debtors Days | Days | 47,411,086 | 32,261,878 | 39,872,295 | 14,039,198 | 54,431,599 | |
Net fixed assets | Rs m | 15 | 14 | 13 | 12 | 12 | |
Share capital | Rs m | 30 | 30 | 30 | 30 | 30 | |
"Free" reserves | Rs m | 34 | 40 | 48 | 56 | 62 | |
Net worth | Rs m | 64 | 70 | 78 | 86 | 92 | |
Long term debt | Rs m | 1 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 83 | 95 | 93 | 113 | 114 | |
Interest coverage | x | 8.6 | 21.4 | 33.9 | 42.7 | 15.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.1 | 1.6 | 1.5 | 1.3 | 1.1 | |
Return on assets | % | 4.9 | 6.1 | 9.3 | 7.4 | 5.5 | |
Return on equity | % | 5.5 | 7.9 | 10.6 | 9.4 | 6.3 | |
Return on capital | % | 8.0 | 10.7 | 13.9 | 12.4 | 9.1 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 10.4 | 18.5 | 9.5 | 24.7 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 9 | 27 | 13 | 35 | 0 | |
Fx inflow | Rs m | 6 | 7 | 17 | 12 | 17 | |
Fx outflow | Rs m | 10 | 27 | 23 | 35 | 0 | |
Net fx | Rs m | -4 | -21 | -6 | -23 | 17 |
ISHITA DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 8 | 10 | -7 | 31 | -29 | |
From Investments | Rs m | -11 | -12 | 25 | -9 | 6 | |
From Financial Activity | Rs m | 1 | 1 | -2 | 0 | 11 | |
Net Cashflow | Rs m | -2 | -0 | 15 | 21 | -13 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Jagdish Agrawal | COMP SEC: Srushti Pandya | YEAR OF INC: 1992 | BSE CODE: 524400 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ISHITA DRUGS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.